Myelodysplastic syndromes Trials in Rochester, United States
Conditions / Myelodysplastic syndromes / Rochester, United States
Myelodysplastic syndromes is a medical condition with active clinical research programs worldwide.
49 total trials for this combination
Showing top 10 of 49 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00516503 | Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer | COMPLETED | PHASE3 |
| NCT04904588 | HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00028899 | Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes | COMPLETED | PHASE1 |
| NCT00003793 | Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma | COMPLETED | — |
| NCT03904134 | Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) | COMPLETED | NA |
| NCT00719563 | American Ginseng in Treating Patients With Fatigue Caused by Cancer | COMPLETED | PHASE3 |
| NCT03016806 | Umbilical Cord Blood Transplantation From Unrelated Donors | RECRUITING | — |
| NCT00003593 | Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome | COMPLETED | PHASE3 |
| NCT06001385 | HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT00255684 | Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer | TERMINATED | NA |